Diagnosis of pertussis: A historical review and recent developments

Expert Review of Molecular Diagnostics

Volumn 6, Issue 6, 2006, Pages 857-864

  Wendelboe, Aaron Mark ^a,b,c   Van Rie, Annelies ^c  

^a AMW ^*  (United States)

^b AMW   (United States)

^c IL   (United States)

Author keywords

Culture; DFA; Epidemiology; Paired and single serology; PCR; Sensitivity; Specificity; Symptoms

Indexed keywords

ADENYLATE CYCLASE; ANTIBIOTIC AGENT; PERTUSSIS VACCINE;

BACTERIAL INFECTION; BACTERIUM CULTURE; BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS; CLINICAL FEATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENE TARGETING; HUMAN; LABORATORY DIAGNOSIS; PERTUSSIS; POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; SEROLOGY; WORLD HEALTH ORGANIZATION;

BORDETELLA PERTUSSIS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; IMMUNOENZYME TECHNIQUES; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; WHOOPING COUGH;

EID: 33845433775     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.6.6.857     Document Type: Review

References (94)

1. Versteegh FG, Schellekens J, Fleer A, Roord JJ. Pertussis: a concise historical review including diagnosis, incience, clinical manifestations and the role of treatment and vaccination in management. Rev. Med. Microbiol. 16(3), 79-89 (2005).
2. Cherry JD, Grimprel E, Guiso N, Heininger U, Mertsola J. Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr. Infect. Dis. J. 24(Suppl. 5), S25-S34 (2005).
3. Hewlett E. Bordetella species. Principles and Practice of Infectious Diseases, 5th Edition. Mandell GL, Bennett JE, Dolin R (Eds). Churchill Livingstone, PA, USA (2000).
4. Long SS, Welkon CJ, Clark JL. Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology. J. Infect. Dis. 161(3), 480-486 (1990).
5. Long SS, Lischner HW, Deforest A, Clark JL. Serologic evidence of subclinical pertussis in immunized children. Pediatr. Infect. Dis. J. 9(10), 700-705 (1990).
6. Tanaka M, Vitek CR, Pascual FB et al. Trends in pertussis among infants in the United States, 1980-1999. JAMA 290(22), 2968-2975 (2003).
7. De Serres G, Shadmani R, Duval B et al. Morbidity of pertussis in adolescents and adults. J. Infect. Dis. 182(1), 174-179 (2000).
8. Deeks S, De Serres G, Boulianne N et al. Failure of physicians to consider the diagnosis of pertussis in children. Clin. Infect. Dis. 28(4), 840-846 (1999).
9. Steketee RW, Burstyn DG, Wassilak SG et al. A comparison of laboratory and clinical methods for diagnosing pertussis in an outbreak in a facility for the developmentally disabled. J. Infect. Dis. 157(3), 441-449 (1988).
10. Patriarca PA, Biellik RJ, Sanden G et al. Sensitivity and specificity of clinical case definitions for pertussis. Am. J. Public Health 78(7), 833-836 (1988).
11. Bisgard KM, Pascual FB, Ehresmann KR et al. Infant pertussis: who was the source? Pediatr. Infect. Dis. J. 23(11), 985-989 (2004).
12. Wirsing von Konig CH, Campins-Marti M, Finn A et al. Pertussis immunization in the global pertussis initiative European region: recommended strategies and implementation considerations. Pediatr. Infect. Dis. J. 24(Suppl. 5), S87-S92 (2005).
13. Friedman RL. Pertussis: the disease and new diagnostic methods. Clin. Microbiol. Rev. 1(4), 365-376 (1988).
14. Granstrom G, Wretlind B, Granstrom M. Diagnostic value of clinical and bacteriological findings in pertussis. J. Infect. 22(1), 17-26 (1991).
15. Regan J, Lowe F. Enrichment medium for the isolation of Bordetella. J. Clin. Microbiol. 6(3), 303-309 (1977).
16. Aoyama T, Goto A, Iwai H et al. Simple and efficient method for clinical isolation of Bordetella pertussis. Dev. Biol. Stand. 73, 185-192 (1991).
17. Dragsted DM, Dohn B, Madsen J, Jensen JS. Comparison of culture and PCR for detection of Bordetella pertussis and Bordetella parapertussis under routine laboratory conditions. J. Med. Microbiol. 53(Pt 8), 749-754 (2004).
18. Katzko G, Hofmeister M, Church D. Extended incubation of culture plates improves recovery of Bordetella spp. J. Clin. Microbiol. 34(6), 1563-1564 (1996).
19. Hallander HO, Reizenstein E, Renemar B et al. Comparison of nasopharyngeal aspirates with swabs for culture of Bordetella pertussis. J. Clin. Microbiol. 31(1), 50-52 (1993).
20. Marcon MJ, Hamoudi AC, Cannon HJ, Hribar MM. Comparison of throat and nasopharyngeal swab specimens for culture diagnosis of Bordetella pertussis infection. J. Clin. Microbiol. 25(6), 1109-1110 (1987).
21. Cloud JL, Hymas W, Carroll KC. Impact of nasopharyngeal swab types on detection of Bordetella pertussis by PCR and culture. J. Clin. Microbiol. 40(10), 3838-3840 (2002).
22. Onorato IM, Wassilak SG. Laboratory diagnosis of pertussis: the state of the art. Pediatr. Infect. Dis. J. 6(2), 145-151 (1987).
23. Lind-Brandberg L, Welinder-Olsson C, Lagergard T et al. Evaluation of PCR for diagnosis of Bordetella pertussis and Bordetella parapertussis infections. J. Clin. Microbiol. 36(3), 679-683 (1998).
24. He Q, Mertsola J, Soini H, Viljanen MK. Sensitive and specific polymerase chain reaction assays for detection of Bordetella pertussis in nasopharyngeal specimens. J. Pediatr. 124(3), 421-426 (1994).
25. Schlapfer G, Cherry JD, Heininger U et al. Polymerase chain reaction identification of Bordetella pertussis infections in vaccinees and family members in a pertussis vaccine efficacy trial in Germany. Pediatr. Infect. Dis. J. 14(3), 209-214 (1995).
26. Templeton KE, Scheltinga SA, Van Der Zee A et al. Evaluation of real-time PCR for detection of and discrimination between Bordetella pertussis, Bordetella parapertussis, and Bordetella holmesii for clinical diagnosis. J. Clin. Microbiol. 41(9), 4121-4126 (2003).
27. Chan EL, Antonishyn N, McDonald R et al. The use of TaqMan PCR assay for detection of Bordetella pertussis infection from clinical specimens. Arch. Pathol. Lab. Med. 126(2), 173-176 (2002).
28. Heininger U, Cherry JD, Eckhardt T et al. Clinical and laboratory diagnosis of pertussis in the regions of a large vaccine efficacy trial in Germany. Pediatr. Infect. Dis. J. 12(6), 504-509 (1993).
29. Grimprel E, Begue P, Anjak I, Betsou F, Guiso N. Comparison of polymerase chain reaction, culture, and western immunoblot serology for diagnosis of Bordetella pertussis infection. J. Clin. Microbiol. 31(10), 2745-2750 (1993).
30. van der Zee A, Agterberg C, Peeters M, Mooi F, Schellekens J. A clinical validation of Bordetella pertussis and Bordetella parapertussis polymerase chain reaction: comparison with culture and serology using samples from patients with suspected whooping cough from a highly immunized population. J. Infect. Dis. 174(1), 89-96 (1996).
31. Arico B, Rappuoli R. Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes. J. Bacteriol. 169(6), 2847-2853 (1987).
32. Letowska I, Hryniewicz W. Epidemiology and characterization of Bordetella parapertussis strains isolated between 1995 and 2002 in and around Warsaw, Poland. Eur. J. Clin. Microbiol. Infect. Dis. 23(6), 499-501 (2004).
33. He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. Whooping cough caused by Bordetella pertussis and Bordetella parapertussis in an immunized population. JAMA 280(7), 635-637 (1998).
34. Liese JG, Renner C, Stojanov S, Belohradsky BH. Clinical and epidemiological picture of B pertussis and B parapertussis infections after introduction of acellular pertussis vaccines. Arch. Dis. Child. 88(8), 684-687 (2003).
35. Linnemann CC Jr, Bass JW, Smith MH. The carrier state in pertussis. Am. J. Epidemiol. 88(3), 422-427 (1968).
36. Tilley PA, Kanchana MV, Knight I et al. Detection of Bordetella pertussis in a clinical laboratory by culture, polymerase chain reaction, and direct fluorescent antibody staining; accuracy, and cost. Diagn. Microbiol. Infect. Dis. 37(1), 17-23 (2000).
37. Halperin SA, Bortolussi R, Wort AJ. Evaluation of culture, immunofluorescence, and serology for the diagnosis of pertussis. J. Clin. Microbiol. 27(4), 752-757 (1989).
38. Hallander HO. Microbiological and serological diagnosis of pertussis. Clin. Infect. Dis. 28(Suppl. 2), S99-S106 (1999).
39. Ewanowich CA, Chui LW, Paranchych MG et al. Major outbreak of pertussis in northern Alberta, Canada: analysis of discrepant direct fluorescent-antibody and culture results by using polymerase chain reaction methodology. J. Clin. Microbiol. 31(7), 1715-1725 (1993).
40. McNicol P, Giercke SM, Gray M et al. Evaluation and validation of a monoclonal immunofluorescent reagent for direct detection of Bordetella pertussis. J. Clin. Microbiol. 33(11), 2868-2871 (1995).
41. Gilligan PH, Fisher MC. Importance of culture in laboratory diagnosis of Bordetella pertussis infections. J. Clin. Microbiol. 20(5), 891-893 (1984).
42. Houard S, Hackel C, Herzog A, Bollen A. Specific identification of Bordetella pertussis by the polymerase chain reaction. Res. Microbiol. 140(7), 477-487 (1989).
43. Farrell DJ, McKeon M, Daggard G et al. Rapid-cycle PCR method to detect Bordetella pertussis that fulfills all consensus recommendations for use of PCR in diagnosis of pertussis. J. Clin. Microbiol. 38(12), 4499-4502 (2000).
44. Kosters K, Reischl U, Schmetz J, Riffelmann M, Wirsing von Konig CH. Real-time LightCycler PCR for detection and discrimination of Bordetella pertussis and Bordetella parapertussis. J. Clin. Microbiol. 40(5), 1719-1722 (2002).
45. Cloud JL, Hymas WC, Turlak A et al. Description of a multiplex Bordetella pertussis and Bordetella parapertussis LightCycler PCR assay with inhibition control. Diagn. Microbiol. Infect. Dis. 46(3), 189-195 (2003).
46. van der Zee A, Agterberg C, Peeters M, Schellekens J, Mooi FR. Polymerase chain reaction assay for pertussis: simultaneous detection and discrimination of Bordetella pertussis and Bordetella parapertussis. J. Clin. Microbiol. 31(8), 2134-2140 (1993).
47. Meade BD, Bollen A. Recommendations for use of the polymerase chain reaction in the diagnosis of Bordetella pertussis infections. J. Med. Microbiol. 41(1), 51-55 (1994).
48. Riffelmann M, Wirsing von Konig CH, Caro V, Guiso N. Nucleic Acid amplification tests for diagnosis of Bordetella infections. J. Clin. Microbiol. 43(10), 4925-4929 (2005). • Published recommendations from the Pertussis Consensus Group are important in the standardization and advancement of PCR in diagnosing pertussis.
49. Reischl U, Lehn N, Sanden GN, Loeffelholz MJ. Real-time PCR assay targeting IS481 of Bordetella pertussis and molecular basis for detecting Bordetella holmesii. J. Clin. Microbiol. 39(5), 1963-1966 (2001).
50. Antila M, He Q, de Jong C et al. Bordetella holmesii DNA is not detected in nasopharyngeal swabs from Finnish and Dutch patients with suspected pertussis. J. Med. Microbiol. 55(Pt 8), 1043-1051 (2006).
51. van der Zee A, Agterberg C, van Agterveld M, Peeters M, Mooi FR. Characterization of IS1001, an insertion sequence element of Bordetella parapertussis. J. Bacteriol. 175(1), 141-147 (1993).
52. Sloan LM, Hopkins MK, Mitchell PS et al. Multiplex LightCycler PCR assay for detection and differentiation of Bordetella pertussis and Bordetella parapertussis in nasopharyngeal specimens. J. Clin. Microbiol. 40(1), 96-100 (2002).
53. Douglas E, Coote JG, Parton R, McPheat W. Identification of Bordetella pertussis in nasopharyngeal swabs by PCR amplification of a region of the adenylate cyclase gene. J. Med. Microbiol. 38(2), 140-144 (1993).
54. Li Z, Jansen DL, Finn TM et al. Identification of Bordetella pertussis infection by shared-primer PCR. J. Clin. Microbiol. 32(3), 783-789 (1994).
55. Glare EM, Paton JC, Premier RR, Lawrence AJ, Nisbet IT. Analysis of a repetitive DNA sequence from Bordetella pertussis and its application to the diagnosis of pertussis using the polymerase chain reaction. J. Clin. Microbiol. 28(9), 1982-1987 (1990).
56. Fry NK, Tzivra O, Li YT et al. Laboratory diagnosis of pertussis infections: the role of PCR and serology. J. Med. Microbiol. 53(Pt 6), 519-525 (2004).
57. Chia JH, Su LH, Lin PY et al. Comparison of multiplex polymerase chain reaction, culture, and serology for the diagnosis of Bordetella pertussis infection. Chang Gung Med. J. 27(6), 408-415 (2004).
58. Heininger U, Schmidt-Schlapfer G, Cherry JD, Stehr K. Clinical validation of a polymerase chain reaction assay for the diagnosis of pertussis by comparison with serology, culture, and symptoms during a large pertussis vaccine efficacy trial. Pediatrics 105(3), E31 (2000).
59. He Q, Schmidt-Schlapfer G, Just M et al. Impact of polymerase chain reaction on clinical pertussis research: Finnish and Swiss experiences. J. Infect. Dis. 174(6), 1288-1295 (1996).
60. Qin X, Turgeon DK, Ingersoll BP et al. Bordetella pertussis PCR: simultaneous targeting of signature sequences. Diagn. Microbiol. Infect. Dis. 43(4), 269-275 (2002).
61. Kosters K, Riffelmann M, Wirsing von Konig CH. Evaluation of a realtime PCR assay for detection of Bordetella pertussis and B. parapertussis in clinical samples. J. Med. Microbiol. 50(5), 436-440 (2001).
62. Knorr L, Fox JD, Tilley PA, Ahmed-Bentley J. Evaluation of real-time PCR for diagnosis of Bordetella pertussis infection. BMC Infect. Dis. 6, 62 (2006).
63. Lievano FA, Reynolds MA, Waring AL et al. Issues associated with and recommendations for using PCR to detect outbreaks of pertussis. J. Clin. Microbiol. 40(8), 2801-2805 (2002).
64. Muyldermans G, Soetens O, Antoine M et al. External quality assessment for molecular detection of Bordetella pertussis in European laboratories. J. Clin. Microbiol. 43(1), 30-35 (2005).
65. Erlandsson A, Backman A, Tornqvist E, Olcen P. PCR assay or culture for diagnosis of Bordetella pertussis in the routine diagnostic laboratory? J. Infect. 35(3), 221-224 (1997).
66. Broder KR, Cortese MM, Iskander JK et al. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly Rep. 55, 1-43 (2006). • Recent recommendation to provide acellular boosters for adolescents and adults will have an important impact on the epidemiology of pertussis.
67. Muller FM, Hoppe JE, Wirsing von Konig CH. Laboratory diagnosis of pertussis: state of the art in 1997. J. Clin. Microbiol. 35(10), 2435-2443 (1997).
68. Englund JA, Decker MD, Edwards KM et al. Acellular and whole-cell pertussis vaccines as booster doses: a multicenter study. Pediatrics 93(1), 37-43 (1994).
69. Trollfors B, Lagergard T, Gunnarsson E, Taranger J. Determination of pertactin IgG antibodies for the diagnosis of pertussis. Clin. Microbiol. Infect. 9(7), 585-589 (2003).
70. Mink CM, Cherry JD, Christenson P et al. A search for Bordetella pertussis infection in university students. Clin. Infect. Dis. 14(2), 464-471 (1992).
71. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev. 18(2), 326-382 (2005).
72. Le T, Cherry JD, Chang SJ et al. Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study. J. Infect. Dis. 190(3), 535-544 (2004).
73. Mertsola J, Ruuskanen O, Kuronen T, Meurman O, Viljanen MK. Serologic diagnosis of pertussis: evaluation of pertussis toxin and other antigens in enzyme-linked immunosorbent assay. J. Infect. Dis. 161(5), 966-971 (1990).
74. Granstrom M, Granstrom G, Lindfors A, Askelof P. Serologic diagnosis of whooping cough by an enzyme-linked immunosorbent assay using fimbrial hemagglutinin as antigen. J. Infect. Dis. 146(6), 741-745 (1982).
75. Mertsola J, Ruuskanen O, Eerola E, Viljanen MK. Intrafamilial spread of pertussis. J. Pediatr. 103(3), 359-363 (1983).
76. de Melker HE, Versteegh FG, Conyn-Van Spaendonck MA et al. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J. Clin. Microbiol. 38(2), 800-806 (2000). • Important study providing evidence for the routine use of single serological methods in diagnosing pertussis.
77. Conway SP, Balfour AH, Ross H. Serologic diagnosis of whooping cough by enzyme-linked immunosorbent assay. Pediatr. Infect. Dis. J. 7(8), 570-574 (1988).
78. Jackson LA, Cherry JD, Wang SP, Grayston JT. Frequency of serological evidence of Bordetella infections and mixed infections with other respiratory pathogens in university students with cough illnesses. Clin. Infect. Dis. 31(1), 3-6 (2000).
79. Wirsing von Konig CH, Postels-Multani S, Bock HL, Schmitt HJ. Pertussis in adults: frequency of transmission after household exposure. Lancet 346(8986), 1326-1329 (1995).
80. Versteegh FG, Mertens PL, de Melker HE et al. Age-specific long-term course of IgG antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis. Epidemiol. Infect. 133(4), 737-748 (2005).
81. Deville JG, Cherry JD, Christenson PD et al. Frequency of unrecognized Bordetella pertussis infections in adults. Clin. Infect. Dis. 21(3), 639-642 (1995).
82. Yih WK, Silva EA, Ida J et al. Bordetella holmesii-like organisms isolated from Massachusetts patients with pertussis-like symptoms. Emerg. Infect. Dis. 5(3), 441-443 (1999).
83. Giammanco A, Chiarini A, Maple PA et al. European Sero-Epidemiology Network: standardisation of the assay results for pertussis. Vaccine 22(1), 112-120 (2003).
84. Crowcroft NS, Booy R, Harrison T et al. Severe and unrecognised: pertussis in UK infants. Arch. Dis. Child. 88(9), 802-806 (2003).
85. Nardone A, Pebody RG, Maple PA et al. Sero-epidemiology of Bordetella pertussis in England and Wales. Vaccine 22(9-10), 1314-1319 (2004).
86. Horby P, Macintyre CR, McIntyre PB et al. A boarding school outbreak of pertussis in adolescents: value of laboratory diagnostic methods. Epidemiol. Infect. 133(2), 229-236 (2005).
87. Baughman AL, Bisgard KM, Edwards KM et al. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin. Diagn. Lab. Immunol. 11(6), 1045-1053 (2004).
88. Granstrom G, Granstrom M. Effect of erythromycin treatment on antibody responses in pertussis. Scand. J. Infect. Dis. 26(4), 453-457 (1994).
89. Wirsing von Konig CH, Halperin S, Riffelmann M, Guiso N. Pertussis of adults and infants. Lancet Infect. Dis. 2(12), 744-750 (2002).
90. Kosters K, Riffelmann M, Dohrn B, von Konig CH. Comparison of five commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis. Clin. Diagn. Lab. Immunol. 7(3), 422-426 (2000).
91. Marchant CD, Loughlin AM, Lett SM et al. Pertussis in Massachusetts, 1981-1991: incidence, serologic diagnosis, and vaccine effectiveness. J. Infect. Dis. 169(6), 1297-1305 (1994).
92. Finger H. Bordetella. In: Medical Mircobiology. Baron S (Ed.). Churchill Livingstone, NY, USA (1991).
93. Websites 101 Program NI. Pertussis. (Centers for Disease Control and Prevention, 2004) http://www.cdc.gov/nip/publications/pink/pert.pdf
94. Team DoVaBVAaM. Pertussis.(The World Health Organization, Geneva) http://www.who.int/vaccinessurveillance/deseasedesc/RSS_pertus.htm. • Provides standard case definitions and fundamental approaches to conduct pertussis surveillance.